Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 371

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 371
---
 
 ​ | For the Three MonthsEnded June 30, 
 2025                               
 ​                                  | ​ |  ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2024 
 ​    | ​ |  ​ | ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | For the Six MonthsEnded June 30, 
 2025                             
 ​                                | ​ |  ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2024 
 ​    | ​ |  ​ | ​ | ​ 
 ​ 
 ​ |
|:---------------------|:--|:--|:-----------------------------------|:--|---:|:--|:--|:--|:-----|:--|---:|:--|:--|:--|:---------------------------------|:--|---:|:--|:--|:--|:-----|:--|---:|:--|:--|
| Operating lease cost | ​ | ​ | ​                                  | $ | 24 | ​ | ​ | ​ | ​    | $ | 23 | ​ | ​ | ​ | ​                                | $ | 48 | ​ | ​ | ​ | ​    | $ | 45 | ​ | ​ |
| Variable lease cost  | ​ | ​ | ​                                  | ​ | 18 | ​ | ​ | ​ | ​    | ​ | 17 | ​ | ​ | ​ | ​                                | ​ | 40 | ​ | ​ | ​ | ​    | ​ | 38 | ​ | ​ |
| Total lease costs    | ​ | ​ | ​                                  | $ | 42 | ​ | ​ | ​ | ​    | $ | 40 | ​ | ​ | ​ | ​                                | $ | 88 | ​ | ​ | ​ | ​    | $ | 83 | ​ | ​ |

Supplemental disclosure of cash flow information related to the lease were as follows (in thousands):

| ​                                          
 ​                                          | ​ 
 ​ | ​ 
 ​ | For the Three MonthsEnded June 30, 
 2025                               |   |    |   | ​ | ​ | 2024 |   |    |   | ​ 
 ​ | ​ 
 ​ | For the Six MonthsEnded June 30, 
 2025                             |   |     |   | ​ | ​ | 2024 |   |    |   | ​ 
 ​ |
|:-------------------------------------------|:--|:--